Sign inJoin waitlistJoin the waitlist

Alexander Pearson

Associate Professor of Medicine · University of Chicago Medical Center

Credentials: · · · · ·

History

University of Chicago Medical Center
Present

University of Michigan Health-Ann Arbor
2014–2016
Internal Medicine
University of Michigan Health-Ann Arbor
2011–2014
University of Rochester School of Medicine and Dentistry
2006–2010

Research

Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
Nature Medicine · 2019 · 946 citations
Pan-cancer image-based detection of clinically actionable genetic alterations
Nature Cancer · 2020 · Co-senior of 28 authors · Corresponding · 440 citations
Deep learning in cancer pathology: a new generation of clinical biomarkers
Review · British Journal of Cancer · 2021 · 427 citations

Frederick Howard
30 papers · 7 as a fellow
Nishant Agrawal
27 papers
James Dolezal
25 papers · 16 as a fellow
Ari Rosenberg
22 papers · 2 as a fellow
Mark Lingen
22 papers
JN
Jacques Nor
19 papers
Everett Vokes
18 papers
Nicole Cipriani
15 papers
Aditya Juloori
12 papers
EB
Elizabeth Blair
10 papers
Olufunmilayo Olopade
9 papers
Rita Nanda
9 papers

Grants

PROSPECT: Premalignant Oral Lesions Pathology and Epigenetic Risk Prediction Tool
National Cancer Institute · R01
PI · $679.3K · Loma Linda University
2024–2030
Data Science and Medical Image Analysis Training for Improved Health Care Delivery in Nigeria - DATICAN
National Institute of Biomedical Imaging and Bioengineering · UE5
PI · $671.9K · Lagos State University Teaching Hospital
2023–2026
Deep Learning for Oral Premalignancy Evaluation
National Institute of Dental and Craniofacial Research · R56
Contact PI · $330.6K · University of Chicago
2021–2024
A Reasoned Approach to Combination Therapy Development in Head and Neck Cancer
National Institute of Dental and Craniofacial Research · K08
Contact PI · $800.3K · University of Chicago
2016–2021

Clinical trials

Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors
Principal investigator · Active not recruiting · Phase 2
University of Chicago
2018–2032
A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study
Principal investigator · Completed · Phase 2
University of Chicago
2017–2025
Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial
Site PI · Recruiting
Dana-Farber Cancer Institute
2021–2030
Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
Site PI · Recruiting · Phase 2
Dana-Farber Cancer Institute
2020–2029